Author

April Naegeli 1

1 Eli Lilly and Company,Indianapolis,

EFFICACY AND IMPROVED HEALTH-RELATED QUALITY OF LIFE AFTER 52-WEEKS OF MIRIKIZUMAB TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: AN UPDATE FROM A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY

Marc Ferrante, William Sandborn, Bal R Bandhari, Geert D’Haens, Brian G. Feagan, Michael Durante, Vipin Arora, Jay Tuttle, April Naegeli

Efficacy and Safety of Mirikizumab (LY3074828) in a Phase 2 Study of Patients with Crohn's Disease

Bruce E. Sands, William Sandborn, Laurent Peyrin-Biroulet, Peter Higgins, Fumihito Hirai, Ruth Belin, Elisa Gomez Valderas, Debra Miller, MaryAnn Morgan-Cox, April Naegeli, Paul Pollack, Jay Tuttle, Toshifumi Hibi

EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE

Bruce E. Sands, William Sandborn, Laurent Peyrin-Biroulet, Peter Higgins, Fumihito Hirai, Vipul Jairath, Geert R. D'Haens, Maria T. Abreu, Ruth Belin, Elisa Gomez Valderas, Debra Miller, April Naegeli, Vipin Arora, Paul Pollack, Jay Tuttle, Toshifumi Hibi

EFFICACY OF MIRIKIZUMAB ON HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ULCERATIVE COLITIS: A RANDOMISED, DOUBLE-BLIND, CONTROLLED, PHASE 2 STUDY

William Sandborn, Marc Ferrante, Bal R. Bhandari, Geert R. D'Haens, Elina Berliba, Brian G. Feagan, Paul Klekotka, Janelle Laskowski, Michael Durante, Jay Tuttle, April Naegeli

EVALUATION OF SYMPTOM IMPROVEMENT DURING INDUCTION IN PATIENTS WITH CROHN'S DISEASE TREATED WITH MIRIKIZUMAB

William Sandborn, Bruce E. Sands, Pieter Hindryckx, Monika Fischer, Kim Isaacs, April Naegeli, Debra Miller, Elisa Gomez Valderas, Noah Agada, Paul Pollack, Geert R. D'Haens

Impact of Biologic Treatment of Crohn's Disease on Healthcare Resource Utilization in US Patients

Theresa Hunter, April Naegeli, Casey Choong, Yan Dong, Wallace Crandall

Impact of Biologic Treatment of Ulcerative Colitis on Healthcare Resource Utilization in US Patients

April Naegeli, Theresa Hunter, Yan Dong, Casey Choong, Wallace Crandall

Impact of Mirikizumab Treatment on Inflammatory Bowel Disease Questionnaire Scores in Patients with Moderate to Severely Active Crohn's Disease

Bruce E. Sands, William Sandborn, Laurent Peyrin-Biroulet, Peter Higgins, Fumihito Hirai, Vipul Jairath, Ruth Belin, Yan Dong, Elisa Gomez Valderas, Debra Miller, MaryAnn Morgan-Cox, April Naegeli, Paul Pollack, Jay Tuttle, Toshifumi Hibi

THE ASSOCIATION BETWEEN PATIENT ACTIVATION AND HEALTH-RELATED QUALITY OF LIFE AMONG INDIVIDUALS WITH CROHN'S DISEASE

Theresa Hunter, Bridget Balkaran, April Naegeli, Mingyang Shan, Lulu Lee, Vipul Jairath

Trends in healthcare resource utilization and medication use of pediatric crohn´s disease patients in the United States, 2007-2017

Theresa Hunter, April Naegeli, Casey Choong, Yan Dong, Wallace Crandall

Item 11 - 20 / 21
1
2
3